An on-body injector system includes a drug container assembly including a container, a seal member, and a sealing interface between the seal member and the container. The container includes an opening and the seal member at least partially covers the opening in the container. A fluid pathway assembly is coupled to the drug container assembly and includes a needle that is movable between a storage position, in which a point of the needle is spaced from the seal member, and a delivery position, in which the point of the needle is disposed at least partially through the seal member. A radiation generator is configured to emit rays of radiation to sterilize and/or disinfect the sealing interface. A barrier is disposed adjacent to the sealing interface and has an opening. At least a portion of the drug container assembly is positioned adjacent to the opening in the barrier.

An on-body injector system includes a drug container assembly including a container, a seal member, and a sealing interface between the seal member and the container. The container includes an opening and the seal member at least partially covers the opening in the container. A fluid pathway assembly is coupled to the drug container assembly and includes a needle that is movable between a storage position, in which a point of the needle is spaced from the seal member, and a delivery position, in which the point of the needle is disposed at least partially through the seal member. A radiation generator is configured to emit rays of radiation to sterilize and/or disinfect the sealing interface. A barrier is disposed adjacent to the sealing interface and has an opening. At least a portion of the drug container assembly is positioned adjacent to the opening in the barrier.

An on-body injector system includes a drug container assembly including a container, a seal member, and a sealing interface between the seal member and the container. The container includes an opening and the seal member at least partially covers the opening in the container. A fluid pathway assembly is coupled to the drug container assembly and includes a needle that is movable between a storage position, in which a point of the needle is spaced from the seal member, and a delivery position, in which the point of the needle is disposed at least partially through the seal member. A radiation generator is configured to emit rays of radiation to sterilize and/or disinfect the sealing interface. A barrier is disposed adjacent to the sealing interface and has an opening. At least a portion of the drug container assembly is positioned adjacent to the opening in the barrier.

An on-body injector system includes a drug container assembly including a container, a seal member, and a sealing interface between the seal member and the container. The container includes an opening and the seal member at least partially covers the opening in the container. A fluid pathway assembly is coupled to the drug container assembly and includes a needle that is movable between a storage position, in which a point of the needle is spaced from the seal member, and a delivery position, in which the point of the needle is disposed at least partially through the seal member. A radiation generator is configured to emit rays of radiation to sterilize and/or disinfect the sealing interface. A barrier is disposed adjacent to the sealing interface and has an opening. At least a portion of the drug container assembly is positioned adjacent to the opening in the barrier.

A drug delivery sterilization system includes a housing defining at least one receptacle, a container assembly having first and second ends, an elongated portion extending therebetween, and an electron beam or x-ray generator disposed near the housing. The container assembly includes a container having a container contact region at the second end and an inner volume to contain a medicament, a seal member having a seal member contact region to form a sealing interface with the container contact region, and a coupling device adapted to sealingly couple the seal member to the container. The container assembly is at least partially disposed in the receptacle such that the second end of the container is exposed through the housing. The electron beam or x-ray generator generates a sterilizing beam that penetrates the seal member to sterilize the sealing interface.

A drug delivery sterilization system includes a housing defining at least one receptacle, a container assembly having first and second ends, an elongated portion extending therebetween, and an electron beam or x-ray generator disposed near the housing. The container assembly includes a container having a container contact region at the second end and an inner volume to contain a medicament, a seal member having a seal member contact region to form a sealing interface with the container contact region, and a coupling device adapted to sealingly couple the seal member to the container. The container assembly is at least partially disposed in the receptacle such that the second end of the container is exposed through the housing. The electron beam or x-ray generator generates a sterilizing beam that penetrates the seal member to sterilize the sealing interface.

Disclosed is a ceramic shielding apparatus including at least one shield made of a ceramic material and provided inside or outside an X-ray tube to shield radiation; and supports configured to support the shield. According to such a configuration, disadvantages of conventional shielding materials such as lead can be addressed, so that a shield apparatus having excellent shielding properties while being harmless to the human body can be provided.

Disclosed is a ceramic shielding apparatus including at least one shield made of a ceramic material and provided inside or outside an X-ray tube to shield radiation; and supports configured to support the shield. According to such a configuration, disadvantages of conventional shielding materials such as lead can be addressed, so that a shield apparatus having excellent shielding properties while being harmless to the human body can be provided.

Provided is an X-ray shielding glass having high shielding capability against X-rays with a tube voltage of 150 kV or less. The X-ray shielding glass has a composition including: 15 mass % to 25 mass % B.sub.2O.sub.3; 7 mass % to 50 mass % La.sub.2O.sub.3; 7 mass % to 50 mass % Gd.sub.2O.sub.3; 10 mass % to 25 mass % WO.sub.3; 0 mass % to 7 mass % SiO.sub.2; 0 mass % to 10 mass % ZrO.sub.2; 0 mass % to 8 mass % Nb.sub.2O.sub.5; 0 mass % to 10 mass % Ta.sub.2O.sub.5; 0 mass % to 5 mass % Bi.sub.2O.sub.3; 0 mass % to 3 mass % CeO.sub.2; and 0 mass % to 1 mass % Sb.sub.2O.sub.3, wherein the glass contains no ZnO, the total content of La.sub.2O.sub.3 and Gd.sub.2O.sub.3 is 45 mass % to 65 mass %, and when the thickness of the glass is 3 mm, the transmittance of the glass to an X-ray from an X-ray tube with a tube voltage of 60 kV is 0.0050% or less, and the transmittance of the glass to an X-ray from an X-ray tube with a tube voltage of 100 kV is 0.1500% or less.

Provided is an X-ray shielding glass having high shielding capability against X-rays with a tube voltage of 150 kV or less. The X-ray shielding glass has a composition including: 15 mass % to 25 mass % B.sub.2O.sub.3; 7 mass % to 50 mass % La.sub.2O.sub.3; 7 mass % to 50 mass % Gd.sub.2O.sub.3; 10 mass % to 25 mass % WO.sub.3; 0 mass % to 7 mass % SiO.sub.2; 0 mass % to 10 mass % ZrO.sub.2; 0 mass % to 8 mass % Nb.sub.2O.sub.5; 0 mass % to 10 mass % Ta.sub.2O.sub.5; 0 mass % to 5 mass % Bi.sub.2O.sub.3; 0 mass % to 3 mass % CeO.sub.2; and 0 mass % to 1 mass % Sb.sub.2O.sub.3, wherein the glass contains no ZnO, the total content of La.sub.2O.sub.3 and Gd.sub.2O.sub.3 is 45 mass % to 65 mass %, and when the thickness of the glass is 3 mm, the transmittance of the glass to an X-ray from an X-ray tube with a tube voltage of 60 kV is 0.0050% or less, and the transmittance of the glass to an X-ray from an X-ray tube with a tube voltage of 100 kV is 0.1500% or less.